No Data
No Data
Yaxiang Co., Ltd. (301220.SZ): 2023 equity distribution, 10 transfers of 2 yuan, share registration date May 23
Gelonghui, May 16, 丨 Yaxiang Co., Ltd. (301220.SZ) announced that the company's 2023 equity distribution plan is based on the current total share capital of 80,800,000 shares of the company as of the date of the shareholders' meeting after deducting 79,927,100 shares after deducting 872,900 shares already repurchased, and to distribute RMB 20,000 (tax included) to all shareholders for every 10 shares. The share registration date is May 23, 2024, and the ex-dividend date is May 24, 2024.
Jiangsu's Kunshan Accelerates Innovation
Express News | Yaxiang Co., Ltd.: Close cooperation is being carried out with Jiangnan University on synthetic biology projects related to fragrances
Yaxiang Co., Ltd. (301220.SZ): The production capacity set by the company for Thailand is about 1,700 tons
Gelonghui, May 9 | Yaxiang Co., Ltd. (301220.SZ) said at the company's 2023 annual results briefing that the company's production capacity for Thailand is about 1,700 tons. It is expected that when full production is achieved, the company's overall revenue will increase by about 500 million yuan, and profit will increase by about 120 million yuan.
Yaxiang Co., Ltd. (301220.SZ): Currently, we are in in-depth communication and close cooperation with two professors at Jiangnan University on synthetic biology projects related to fragrances
Gelonghui, May 9, 丨 Yaxiang Co., Ltd. (301220.SZ) said at the company's 2023 annual performance briefing that in the future, we will cooperate with universities in the form of commissioned R&D, technology development, and technology transfer. Currently, we are in close communication and close cooperation with two professors at Jiangnan University on synthetic biology projects related to fragrances.
Yaxiang Co., Ltd. (301220.SZ): The company set up a team to complete synthetic biology in 2023
Gelonghui, May 9, 丨 Yaxiang Co., Ltd. (301220.SZ) said at the company's 2023 annual performance briefing that the company set up and completed a synthetic biology team in 2023. Dr. Chen, who graduated from Jiangnan University, was the leader of the company's synthetic biology project to conduct research on related synthetic biology. In addition, the company is also developing related products through cooperation with universities and some external biological research and development companies. At present, the company's new R&D building has basically been completed, and we have built a 1,200-square-meter synthetic biology laboratory. In the future, the company will cooperate with specialists in the field of synthetic biology
No Data